Aurinia Pharmaceuticals's total assets for Q4 2025 were $751.59M, an increase of 42.47% from the previous quarter. AUPH total liabilities were $170.26M for the fiscal quarter, a 5.25% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.